EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice

Poongothai Venkatachalapathy iD, Sruthi Padhilahouse iD, Mohan Sellappan iD, Tharunika Subramanian iD, Shilia Jacob Kurian, Sonal Sekhar Miraj, Mahadev Rao, Ashwin Ashok Raut, Rupinder Kaur Kanwar, Jitendra Singh, Sagar Khadanga, Sukumar Mondithoka und 1 weitere

Pharmacogenomics and Personalized Medicine · 2021-11 · Volume 14 · 1441-1455

DOI: 10.2147/pgpm.s329787 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2021-11. Verfasst von Poongothai Venkatachalapathy und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Karpagam College of Pharmacy, Coimbatore, Tamilnadu, India. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

antidiabetic drugspersonalized medicinepharmacogenomicstype 2 diabetes

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Karpagam College of Pharmacy, Coimbatore, Tamilnadu, India.
  • Karpagam Faculty of Medical Sciences and Research, Coimbatore, India.
  • Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Translational Medicine Centre, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
  • Department of General Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.

ORCID-Profile: Poongothai Venkatachalapathy, Sruthi Padhilahouse, Mohan Sellappan, Tharunika Subramanian, Murali Munisamy

Zitieren

APA

Venkatachalapathy, P., Padhilahouse, S., Sellappan, M., Subramanian, T., Kurian, S. J., Miraj, S. S., Rao, M., Raut, A. A., Kanwar, R. K., Singh, J., Khadanga, S., Mondithoka, S., & Munisamy, M. (2021). Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice. Pharmacogenomics and Personalized Medicine, Volume 14, 1441-1455. https://doi.org/10.2147/pgpm.s329787

Vancouver

Venkatachalapathy P, Padhilahouse S, Sellappan M, Subramanian T, Kurian SJ, Miraj SS, et al. Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice. Pharmacogenomics and Personalized Medicine. 2021;Volume 14:1441-1455. doi:10.2147/pgpm.s329787

BibTeX
@article{Venkatachalapathy2021,
  author = {Venkatachalapathy, Poongothai and Padhilahouse, Sruthi and Sellappan, Mohan and Subramanian, Tharunika and Kurian, Shilia Jacob and Miraj, Sonal Sekhar and Rao, Mahadev and Raut, Ashwin Ashok and Kanwar, Rupinder Kaur and Singh, Jitendra and Khadanga, Sagar and Mondithoka, Sukumar and Munisamy, Murali},
  title = {Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice},
  journal = {Pharmacogenomics and Personalized Medicine},
  year = {2021},
  volume = {Volume 14},
  pages = {1441--1455},
  doi = {10.2147/pgpm.s329787}
}
Kostenlos starten →